Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.
| Last: | $0.3018 |
|---|---|
| Change Percent: | 1.99% |
| Open: | $0.29 |
| Close: | $0.2959 |
| High: | $0.316 |
| Low: | $0.285 |
| Volume: | 703,491 |
| Last Trade Date Time: | 02/27/2026 12:43:21 pm |
| Market Cap: | $2,395,329 |
|---|---|
| Float: | 2,930,155 |
| Insiders Ownership: | N/A |
| Institutions: | 11 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.ernexatx.com |
| Country: | US |
| City: | Cambridge |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Eterna Therapeutics Inc. (NASDAQ: ERNA).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
